Plasma Melatonin Levels, Seasonal Variation, and Sleep Quality: A Stratified Analysis of Adults Aged 25-65 Years Using the Pittsburgh Sleep Quality Index and Actigraphy
Abstract
This study aimed to examine plasma melatonin levels, seasonal variation, and their association with sleep quality in adults aged 25-65 years using both the Pittsburgh Sleep Quality Index and actigraphy. A cross-sectional study was conducted in a stratified random sample of 500 adults from Salamanca and Ávila (Spain). Plasma melatonin was quantified by HPLC-DAD-MS/MS, and sleep quality was assessed using the Pittsburgh Sleep Quality Index and a 5-day wrist actigraphy protocol (ActiGraph GT3X+). Participants were stratified by age and sex, and seasonal variation was evaluated. Multivariable analyses were adjusted for relevant confounders. A total of 334 participants with valid melatonin measurements were included (mean age 43 years). Mean plasma melatonin concentration was 14.5 ± 15.9 pg/mL, with higher levels observed in men than women and a decreasing trend with age. A trend toward higher melatonin levels during winter was observed, although the differences were not statistically significant. No significant association was found between plasma melatonin levels and Pittsburgh Sleep Quality Index scores. However, higher melatonin levels were associated with slightly greater sleep efficiency measured by actigraphy. Participants reporting melatonin supplement use showed higher Pittsburgh Sleep Quality Index scores and lower total sleep time compared with non-users. Overall, plasma melatonin levels varied by sex, age, and season but showed no association with subjective sleep…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 500 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.